🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11599+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11599 recruiting trials

NARecruitingNCT05484973

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

👨‍⚕️ Kate Dilligan, Cooler Heads Inc.📍 2 sites📅 Started Nov 2024View details ↗
RecruitingNCT06698614

MEMRI and Kidney Disease

🏥 University of Edinburgh📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06466122

Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi

👨‍⚕️ Kerry A Rogers, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06523569

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

👨‍⚕️ Priya M Freaney, MD, Northwestern University📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06715228

Efficacy of Shitali Respiratory Rehabilitation Program in Obstructive Sleep Apnea

👨‍⚕️ Ali Ismail, lecturer, Cairo University📍 1 site📅 Started Nov 2024View details ↗
Phase 2, PHASE3RecruitingNCT05893888

Safety and Efficacy Study of PRV111 and PRV211 in Subjects With Oral Squamous Cell Carcinoma

🏥 Privo Technologies📍 4 sites📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06700096

An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

👨‍⚕️ Arina Arina V Zinkina-Orikhan, Biocad📍 14 sites📅 Started Nov 2024View details ↗
Phase 1, PHASE2RecruitingNCT06659640

A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

👨‍⚕️ Medical Director, Alnylam Pharmaceuticals📍 8 sites📅 Started Nov 2024View details ↗
RecruitingNCT06380686

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

👨‍⚕️ Victor Grünwald, Prof. Dr., Universitätsklinikum Essen📍 2 sites📅 Started Nov 2024View details ↗
RecruitingNCT06807723

Further Delineation of the De Santo Shinawi Syndrome Phenotype Using a Series of Individuals Carrying a Pathogenic Variant of the WAC Gene

👨‍⚕️ Florian CHERIK, University Hospital, Clermont-Ferrand📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06668961

A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

🏥 Sichuan Baili Pharmaceutical Co., Ltd.📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT05582993

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

👨‍⚕️ Study Director, Takeda📍 15 sites📅 Started Nov 2024View details ↗
RecruitingNCT06794489

Longitudinal Biomarkers With Selected Outcome Measures In CMT

🏥 University Medical Center Goettingen📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06750419

89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study

🏥 Telix Pharmaceuticals (Innovations) Pty Limited📍 8 sites📅 Started Nov 2024View details ↗
Phase 1RecruitingNCT06447987

Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia

👨‍⚕️ Ibrahim Aldoss, City of Hope Medical Center📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06663358

A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients

🏥 Chiesi Farmaceutici S.p.A.📍 10 sites📅 Started Nov 2024View details ↗
RecruitingNCT06162884

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

👨‍⚕️ Samuel Weigt, MD, UCLA Division of Pulmonary, Critical Care, and Hospitals📍 1 site📅 Started Nov 2024View details ↗
Enrolling by InvitationNCT06311331

Prospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement (PROCLAIM)

🏥 Restor3D📍 1 site📅 Started Nov 2024View details ↗
NAEnrolling by InvitationNCT06578117

Statistical Learning as a Novel Intervention for Cortical Blindness

🏥 University of Rochester📍 1 site📅 Started Nov 2024View details ↗
Phase 1, PHASE2RecruitingNCT06488924

An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB

🏥 JCR Pharmaceuticals Co., Ltd.📍 3 sites📅 Started Nov 2024View details ↗
← PreviousPage 209 of 580Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →